Online citations, reference lists, and bibliographies.
← Back to Search

Biocompatible And PH-sensitive PLGA Encapsulated MnO Nanocrystals For Molecular And Cellular MRI.

Margaret F Bennewitz, T. Lobo, M. Nkansah, Gözde Ulas, G. Brudvig, E. Shapiro
Published 2011 · Materials Science, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Inorganic manganese-based particles are becoming attractive for molecular and cellular imaging, due to their ability to provide bright contrast on MRI, as opposed to the dark contrast generated from iron-based particles. Using a single emulsion technique, we have successfully fabricated pH-sensitive poly(lactic-co-glycolic acid) (PLGA)-encapsulated manganese oxide (MnO) nanocrystals. Two classes of particles were fabricated at ∼140 nm and 1.7 μm and incorporated 15 to 20 nm MnO nanocrystals with high encapsulation efficiencies. Intact particles at physiological pH cause little contrast in MRI, but following endocytosis into low pH compartments within the cells, the particles erode and MnO dissolves to release Mn(2+). This causes the cells to appear bright on MR images. The magnitude of the change in MRI properties is as high as 35-fold, making it the most dynamic "smart" MRI contrast agent yet reported. Possible applications of these MnO particles include slow release Mn(2+), tumor targeting, and confirmation of cell uptake.
This paper references
10.1021/JA0362656
Synthesis of monodisperse nanocrystals of manganese oxides.
M. Yin (2003)
10.1016/S0730-725X(00)00198-3
Sequential use of gadolinium chelate and mangafodipir trisodium for the assessment of focal liver lesions: initial observations.
D. Martin (2000)
10.1002/mrm.21622
MR tracking of transplanted cells with “positive contrast” using manganese oxide nanoparticles
A. A. Gilad (2008)
10.1002/mrm.10320
Dynamic activity‐induced manganese‐dependent contrast magnetic resonance imaging (DAIM MRI)
Ichio Aoki (2002)
10.1002/MRM.1910400515
In vivo neuronal tract tracing using manganese‐enhanced magnetic resonance imaging
R. Pautler (1998)
Magnetic resonance imaging of immune cells in inflammation of central nervous system.
I. Pirko (2003)
NIH grants P30 NS052519 and DP2 OD004362
10.1038/nbt1121
In vivo imaging platform for tracking immunotherapeutic cells
E. Ahrens (2005)
10.1002/mrm.20368
Manganese‐enhanced magnetic resonance imaging of mouse brain after systemic administration of MnCl2: Dose‐dependent and temporal evolution of T1 contrast
J. Lee (2005)
10.1021/IC0200390
Mechanistic studies of a calcium-dependent MRI contrast agent.
W. Li (2002)
10.1016/j.neuroimage.2010.01.008
Retrograde axonal tracing using manganese enhanced magnetic resonance imaging
Ken Matsuda (2010)
10.1097/00004647-200208000-00001
In Vivo Magnetic Resonance Tracking of Magnetically Labeled Cells after Transplantation
J. Bulte (2002)
10.1053/CRAD.2002.1117
MnDPDP enhanced magnetic resonance imaging of focal liver lesions.
L. King (2002)
10.1093/CERCOR/BHJ121
Manganese-enhanced MRI reveals structural and functional changes in the cortex of Bassoon mutant mice.
F. Angenstein (2007)
10.1007/s00449-009-0354-5
In vitro cytotoxicity screening of water-dispersible metal oxide nanoparticles in human cell lines
J. Choi (2010)
10.1016/j.neuroimage.2008.07.036
Layer specific tracing of corticocortical and thalamocortical connectivity in the rodent using manganese enhanced MRI
J. Tucciarone (2009)
10.1098/RSTB.1980.0066
Progress in n.m.r. zeugmatography imaging.
P. Lauterbur (1980)
Blood Magn Reson. Med. Nat. Biotechnol
K A Hinds (2000)
10.1039/b902875g
Sensitive and efficient detection of thrombus with fibrin-specific manganese nanocolloids.
D. Pan (2009)
10.1016/0887-2333(88)90030-6
Comparisons of two in vitro cytotoxicity assays-The neutral red (NR) and tetrazolium MTT tests.
E. Borenfreund (1988)
10.1016/j.neuroimage.2006.04.219
Magnetic resonance imaging of the migration of neuronal precursors generated in the adult rodent brain
E. Shapiro (2006)
10.1080/02841859709172400
Metabolism and pharmacokinetics of MnDPDP in man
K. Toft (1997)
10.1002/NBM.945
Manganese‐enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations
A. Silva (2004)
Acid pH in tumors and its potential for therapeutic exploitation.
I. Tannock (1989)
10.1073/pnas.0706247104
The synthesis and in vitro testing of a zinc-activated MRI contrast agent
Jody L. Major (2007)
10.1073/PNAS.0507198103
In situ labeling of immune cells with iron oxide particles: an approach to detect organ rejection by cellular MRI.
Y. Wu (2006)
10.1002/mrm.20718
In vivo detection of single cells by MRI
E. Shapiro (2006)
10.1016/j.biomaterials.2010.01.087
The characteristics of sub 10 nm manganese oxide T1 contrast agents of different nanostructured morphologies.
C. Huang (2010)
10.1021/bc8002259
Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging.
N. Kamaly (2009)
10.1182/BLOOD-2002-12-3669
Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells.
K. A. Hinds (2003)
10.1002/mrm.21631
Convertible manganese contrast for molecular and cellular MRI
E. Shapiro (2008)
10.1002/NBM.1000
Cell labeling for magnetic resonance imaging with the T1 agent manganese chloride
I. Aoki (2006)
10.1038/73780
In vivo visualization of gene expression using magnetic resonance imaging
A. Louie (2000)
10.1007/s007750100290
Stability and transmetallation of the magnetic resonance contrast agent MnDPDP measured by EPR
P. P. Schmidt (2002)
Chem. PNAS
J L Major (2002)
10.4414/SMW.2006.10770
Targeting the epidermal growth factor receptor (EGFR)--a new therapeutic option in oncology?
C. Mamot (2006)
10.1002/anie.200802323
Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery.
Jongmin Shin (2009)
10.2174/1389201043376607
Manganese enhanced magnetic resonance imaging.
J. Lee (2004)
10.1002/NBM.970
A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging
A. Arbab (2005)
10.1002/mrm.22095
Experimental protocol for activation‐induced manganese‐enhanced MRI (AIM‐MRI) based on quantitative determination of Mn content in rat brain by fast T1 mapping
S. Tambalo (2009)
10.1002/mrm.20342
Sizing it up: Cellular MRI using micron‐sized iron oxide particles
E. Shapiro (2005)
10.1002/mrm.20717
Monitoring T‐lymphocyte trafficking in tumors undergoing immune rejection
De-En Hu (2005)
10.1021/BI00793A005
Electron paramagnetic resonance studies of manganese (II) coordination in the phosphoglucomutase system.
G. H. Reed (1971)



This paper is referenced by
10.1021/acsnano.7b05215
Two-Dimensional Graphene Augments Nanosonosensitized Sonocatalytic Tumor Eradication.
Chen Dai (2017)
10.1007/s11051-015-3161-8
Non-degradable contrast agent with selective phagocytosis for cellular and hepatic magnetic resonance imaging
Fei Chen (2015)
10.3390/ma11040596
Efficient Active Oxygen Free Radical Generated in Tumor Cell by Loading-(HCONH2)·H2O2 Delivery Nanosystem with Soft-X-ray Radiotherapy
L. Xu (2018)
10.1039/C6TB02820A
Lysosomes activating chain reactions against cancer cells with a pH-switched prodrug/procatalyst co-delivery nanosystem.
Jingke Fu (2017)
10.1371/journal.pone.0239034
Tuning the size and composition of manganese oxide nanoparticles through varying temperature ramp and aging time
Celia Martinez de la Torre (2020)
10.1039/c4nr01405g
Dual-modality, fluorescent, PLGA encapsulated bismuth nanoparticles for molecular and cellular fluorescence imaging and computed tomography.
Eric R Swy (2014)
10.1021/acsami.5b04999
Marriage Strategy of Structure and Composition Designs for Intensifying Ultrasound & MR & CT Trimodal Contrast Imaging.
K. Zhang (2015)
10.1002/adhm.201200340
Ultrasmall manganese ferrite nanoparticles as positive contrast agent for magnetic resonance imaging.
Zhen Li (2013)
10.21037/qims.2018.10.07
Design and synthesis of magnetic nanoparticles for biomedical diagnostics.
Y. Chen (2018)
10.1016/J.MATERRESBULL.2014.05.023
Folate conjugated Mn3O4@SiO2 nanoparticles for targeted magnetic resonance imaging in vivo
Xinyi Yang (2014)
10.1002/9781118854754.CH9
Nanoparticulate MRI Contrast Agents
J. Gallo (2014)
10.1016/j.jcis.2016.09.010
Terbium-doped manganese carbonate nanoparticles with intrinsic photoluminescence and magnetic resonance imaging capacity.
Kang Liu (2017)
10.1007/s11095-014-1436-x
Tumor-Targeted Responsive Nanoparticle-Based Systems for Magnetic Resonance Imaging and Therapy
Ronak Savla (2014)
10.1002/PPSC.201900014
Dye‐Sensitized Core/Shell Upconversion Nanoparticles for Detecting Nitrites in Plant Cells
Junshan Hu (2019)
NANO EXPRESS Open Access
J. Lorbeer (2014)
10.1021/acsami.7b12216
Radiolabeled, Antibody-Conjugated Manganese Oxide Nanoparticles for Tumor Vasculature Targeted Positron Emission Tomography and Magnetic Resonance Imaging.
Yonghua Zhan (2017)
10.1016/j.biomaterials.2012.11.054
Fe(3)O(4)/MnO hybrid nanocrystals as a dual contrast agent for both T(1)- and T(2)-weighted liver MRI.
G. H. Im (2013)
10.1021/acs.molpharmaceut.5b00216
Dual Receptor-Targeted Theranostic Nanoparticles for Localized Delivery and Activation of Photodynamic Therapy Drug in Glioblastomas.
S. Dixit (2015)
10.1002/jbm.b.33648
Polymer degradation and drug delivery in PLGA-based drug-polymer applications: A review of experiments and theories.
Y. Xu (2017)
10.1039/c3nr03490a
Aptamer-conjugated Mn3O4@SiO2 core-shell nanoprobes for targeted magnetic resonance imaging.
He Hu (2013)
10.1016/j.biomaterials.2013.08.009
Mn(2+)-doped silica nanoparticles for hepatocyte-targeted detection of liver cancer in T1-weighted MRI.
S. Kim (2013)
10.1021/acsami.7b10608
MnO2-Functionalized Co-P Nanocomposite: A New Theranostic Agent for pH-Triggered T1/T2 Dual-Modality Magnetic Resonance Imaging-Guided Chemo-photothermal Synergistic Therapy.
Longhai Jin (2017)
10.1016/j.biomaterials.2019.119631
Susceptibility-weighted imaging for metabolic pathway mapping of low-dosage nanoparticles in organisms.
C. Song (2019)
10.1039/c7cs00316a
Engineering of inorganic nanoparticles as magnetic resonance imaging contrast agents.
D. Ni (2017)
10.1039/C3RA47654E
Hollow periodic mesoporous organosilicas for highly efficient HIFU-based synergistic therapy
Xiaoqin Qian (2014)
10.1021/ACS.CHEMMATER.7B02441
Biocompatible 2D Titanium Carbide (MXenes) Composite Nanosheets for pH-Responsive MRI-Guided Tumor Hyperthermia
C. Dai (2017)
10.7282/T3KS6T83
Tumor responsive targeted multifunctional nanosystems for cancer imaging, chemo- and siRNA therapy
Ronak Savla (2015)
10.1039/C7NJ04242F
Hydrophilic K2Mn4O8 nanoflowers as a sensitive photothermal theragnosis synergistic platform for the ablation of cancer
Yuxuan Peng (2018)
10.1002/mabi.201600305
Molecular Cancer Imaging with Polymeric Nanoassemblies: From Tumor Detection to Theranostics.
P. Mi (2017)
10.1039/c5nr00706b
Lysosome-controlled efficient ROS overproduction against cancer cells with a high pH-responsive catalytic nanosystem.
Jingke Fu (2015)
10.1039/C6TB02833K
Covalent self-assembled nanoparticles with pH-dependent enhanced tumor retention and drug release for improving tumor therapeutic efficiency.
Yongwei Hao (2017)
10.1007/978-3-319-16555-4_4
Nanodiamond-based chemotherapy and imaging.
D. Ho (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar